Phio Pharmaceuticals Corp.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2004 | 338.0% | 338.0% | — |
| FY2005 | 490.9% | 490.9% | — |
| FY2006 | -120,250.0% | -120,250.0% | — |
| FY2007 | -101.5% | -101.5% | — |
| FY2008 | -160.3% | -160.3% | — |
| FY2009 | -2,481.4% | -2,481.4% | — |
| FY2010 | -493.5% | -493.5% | — |
| FY2011 | 432.2% | 432.2% | -149.8% |
| FY2012 | 220.5% | 220.5% | -230.3% |
| FY2013 | -423.4% | -423.4% | -140.1% |
| FY2014 | -320.6% | -320.6% | -95.8% |
| FY2015 | -115.0% | -115.0% | -91.6% |
| FY2016 | -82.9% | -82.9% | -67.1% |
| FY2017 | -679.3% | -679.3% | -303.9% |
| FY2018 | -54.2% | -54.2% | -48.0% |
| FY2019 | -155.0% | -155.0% | -110.8% |
| FY2020 | -67.6% | -66.4% | -55.9% |
| FY2021 | -60.6% | -60.6% | -52.8% |
| FY2022 | -105.9% | -105.9% | -89.6% |
| FY2023 | -140.1% | -140.1% | -115.6% |
| FY2024 | -151.4% | -151.4% | -124.6% |
| FY2025 | -43.2% | -43.2% | -40.5% |